[Chart: Company Logo]
Stock Code: 300086 Stock Abbreviation: Kangzhi Pharmaceutical Announcement No.: 2026-030
Kangzhi Pharmaceutical Co., Ltd.
Announcement Regarding the Company's Product Winning the Bid in the National Traditional Chinese Medicine Procurement Alliance's Centralized Volume-Based Procurement
Kangzhi Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") participated in the centralized volume-based procurement (Procurement Document No.: ZCYLM-2026-1) organized by the National Traditional Chinese Medicine Joint Procurement Office. This procurement was coordinated by the National Traditional Chinese Medicine Joint Procurement Office (hereinafter referred to as the "Joint Procurement Office"), composed of representatives from various provinces (autonomous regions, municipalities) and the Xinjiang Production and Construction Corps, with the Hubei Provincial Healthcare Security Administration responsible for daily operations and implementation.
According to the "Notice on Announcing the Winning Results of the National Traditional Chinese Medicine Procurement Alliance's Centralized Procurement" issued by the Joint Procurement Office on June 17, 2026, the Company's declared product, Ganmao Qingre Granules, successfully won the bid. The relevant details are as follows: